Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 2Unknown 1Terminated 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 8Genitourinary 7Lymphoid 6Endocrine 6NET 5Breast 5Tumor-Agnostic 3Thoracic 3Head & Neck 3CNS 3Plasma cell 1Other hematologic neoplasm 1Gynecologic 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Myeloid, Acute 1Febrile Neutropenia 1Disease 1

Interventions

Cytarabine 465Cyclophosphamide 459fludarabine phosphate 277Rituximab 249Methotrexate 245Etoposide 203fludarabine 200Filgrastim 199Peripheral Blood Stem Cell Transplantation 180Busulfan 169Vincristine 163Dexamethasone 153Daunorubicin 151Azacitidine 145Mycophenolic Acid 142Whole-Body Irradiation 133Tacrolimus 127Imatinib Mesylate 127Cyclosporine 123Granulocyte Colony-Stimulating Factor 118Radiotherapy 113Melphalan 110Idarubicin 103Doxorubicin 101Mitoxantrone 97Antilymphocyte Serum 97Lenalidomide 96Decitabine 96Mercaptopurine 93Prednisone 91

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Positron Emission Tomography Computed Tomography × Other hematologic neoplasm × Clear all
NCT03429387 2022-05-17

PIPPIN

Peter MacCallum Cancer Centre, Australia

Phase NA Completed
147 enrolled
Classical hematologyLymphoidOther hematologic neoplasm

Disease, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡